Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

269
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

685
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
685
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

1.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

293
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
293
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

194
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
194

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic Syndrome and Obstructive Sleep Apnea: Two Sides of the Same Coin.

Sleep·2026
Same author

Adenotonsillectomy in Children With Mild to Moderate Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis.

Pediatric pulmonology·2026
Same author

Meta-analysis of diagnostic test accuracy of pediatric sleep questionnaire and the OSA-18 questionnaire in the screening of pediatric obstructive sleep apnea.

Sleep medicine·2026
Same author

Placebo and nocebo responses in gabapentin enacarbil and pregabalin trials for restless legs syndrome: time-course model-based network meta-analysis and meta-analysis of proportions.

Sleep & breathing = Schlaf & Atmung·2026
Same author

Benefit-risk comparison of gabapentin enacarbil versus pregabalin for restless legs syndrome: A dose-response model-based network meta-analysis.

Sleep & breathing = Schlaf & Atmung·2026
Same author

Adaptive servo-ventilation and cardiovascular mortality in patients with central sleep apnea with heart failure: A meta-analysis and trial sequential analysis.

Sleep medicine·2025

Related Experiment Video

Updated: Feb 10, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K

Obesity Hypoventilation Syndrome.

Imran H Iftikhar1, Joshua Roland2

  • 1Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, The Emory Sleep Center, Emory University School of Medicine, 613 Michael Street, Northeast, Atlanta, GA 30329, USA.

Clinics in Chest Medicine
|May 22, 2018
PubMed
Summary

Obesity hypoventilation syndrome (OHS) involves complex interactions affecting breathing during sleep. Understanding OHS mechanisms and treatments is crucial for improving patient outcomes and reducing mortality risks.

Keywords:
Bilevel PAPCPAPObesity hypoventilation syndromeObstructive sleep apnea

More Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.6K
Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
05:18

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

1.5K

Related Experiment Videos

Last Updated: Feb 10, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K
An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.6K
Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
05:18

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

1.5K

Area of Science:

  • Respiratory Medicine
  • Sleep Medicine
  • Obesity Research

Background:

  • Obesity hypoventilation syndrome (OHS) is a complex condition with centuries of recognition but incompletely understood mechanisms.
  • OHS significantly increases morbidity and mortality compared to other sleep-disordered breathing conditions.
  • The syndrome arises from interactions between obesity, reduced ventilatory drive, and sleep-related respiratory changes.

Purpose of the Study:

  • To review the current understanding of obesity hypoventilation syndrome.
  • To consolidate knowledge on the epidemiology, pathophysiology, and clinical presentation of OHS.
  • To discuss current and emerging treatment strategies for OHS.

Main Methods:

  • Comprehensive literature review of existing research on OHS.
  • Synthesis of data regarding OHS epidemiology and pathophysiology.
  • Analysis of clinical features and treatment outcomes for OHS patients.

Main Results:

  • OHS pathophysiology involves a complex interplay of factors related to obesity and respiratory control.
  • Clinical features of OHS vary but are associated with significant health risks.
  • Treatment approaches for OHS require a multi-faceted strategy.

Conclusions:

  • Further research is needed to fully elucidate OHS mechanisms.
  • Effective management of OHS requires addressing obesity, ventilatory drive, and sleep disturbances.
  • Improved understanding and treatment modalities are essential for managing OHS patients.